Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar Lonial

Showing results (91-100 of 440) with videos related to

Pageof 44
Sort By:
Clinical Lymphoma & Myeloma|May 27, 2008
Multiple myeloma presenting with advanced renal failure: a case report and new treatment optionsS Pierson Gladney, Sagar Lonial, Jonathan L Kaufman
Molecular Cancer Research : MCR|May 28, 2015
When Cancer Fights Back: Multiple Myeloma, Proteasome Inhibition, and the Heat-Shock ResponseShardule P Shah, Sagar Lonial, Lawrence H Boise
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2020
Smoldering Myeloma and the Art of WarSagar Lonial, Madhav V Dhodapkar, S Vincent Rajkumar
Supportive Cancer Therapy|July 18, 2008
Optimizing the management of treatment-related peripheral neuropathy in patients with multiple myelomaG Kesava Reddy, Tariq I Mughal, Sagar Lonial
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 18, 2020
The Role of Early Intervention in High-Risk Smoldering MyelomaNisha S Joseph, Madhav V Dhodapkar, Sagar Lonial
Lancet (London, England)|June 8, 2019
Registering a CD38 antibody upfront for multiple myelomaCraig C Hofmeister, Ajay Nooka, Jonathan L Kaufman, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 22, 2013
Histone deacetylase inhibitors in multiple myeloma: rationale and evidence for their use in combination therapyJonathan L Kaufman, Claire Fabre, Sagar Lonial, et al.
Expert Opinion on Drug Safety|November 15, 2016
Safety of proteasome inhibitors for treatment of multiple myelomaDanielle Schlafer, Katherine S Shah, Elyse Hall Panjic, et al.
Blood Cancer Journal|September 5, 2022
Smoldering multiple myeloma current treatment algorithmsS Vincent Rajkumar, Shaji Kumar, Sagar Lonial, et al.
Blood|April 4, 2015
Treatment options for relapsed and refractory multiple myelomaAjay K Nooka, Efstathios Kastritis, Meletios A Dimopoulos, et al.
Pageof 44

Showing results (91-100 of 440) with videos related to

Sort By:
Pageof 44
Clinical Lymphoma & Myeloma|May 27, 2008
Multiple myeloma presenting with advanced renal failure: a case report and new treatment optionsS Pierson Gladney, Sagar Lonial, Jonathan L Kaufman
Molecular Cancer Research : MCR|May 28, 2015
When Cancer Fights Back: Multiple Myeloma, Proteasome Inhibition, and the Heat-Shock ResponseShardule P Shah, Sagar Lonial, Lawrence H Boise
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2020
Smoldering Myeloma and the Art of WarSagar Lonial, Madhav V Dhodapkar, S Vincent Rajkumar
Supportive Cancer Therapy|July 18, 2008
Optimizing the management of treatment-related peripheral neuropathy in patients with multiple myelomaG Kesava Reddy, Tariq I Mughal, Sagar Lonial
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 18, 2020
The Role of Early Intervention in High-Risk Smoldering MyelomaNisha S Joseph, Madhav V Dhodapkar, Sagar Lonial
Lancet (London, England)|June 8, 2019
Registering a CD38 antibody upfront for multiple myelomaCraig C Hofmeister, Ajay Nooka, Jonathan L Kaufman, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 22, 2013
Histone deacetylase inhibitors in multiple myeloma: rationale and evidence for their use in combination therapyJonathan L Kaufman, Claire Fabre, Sagar Lonial, et al.
Expert Opinion on Drug Safety|November 15, 2016
Safety of proteasome inhibitors for treatment of multiple myelomaDanielle Schlafer, Katherine S Shah, Elyse Hall Panjic, et al.
Blood Cancer Journal|September 5, 2022
Smoldering multiple myeloma current treatment algorithmsS Vincent Rajkumar, Shaji Kumar, Sagar Lonial, et al.
Blood|April 4, 2015
Treatment options for relapsed and refractory multiple myelomaAjay K Nooka, Efstathios Kastritis, Meletios A Dimopoulos, et al.
Pageof 44